Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Cognitive Training for Children with ASD
NCT02918864Phase 2Completed
- Sponsor
- Rush University Medical Center
- Start
- Jun 2016
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Rush University Medical Center. Started Jun 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02918864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918864.